GNMSF News and Press, Genmab

Company Announcement Topline results from Phase 3 EPCORE ®  DLBCL-4 evaluating epcoritamab in combination with lenalidomide demonstrated statistically significant and clinically meaningful improvement in progression-free survival (PFS) in patients with relapsed/refractory (R/R)...

2026-05-14 08:43:03 ET Genmab A/S (GMAB) Q1 2026 Earnings Call May 7, 2026 12:00 PM EDT Company Participants Jan van de Winkel - Co-Founder, President & CEO Brad Bailey - Executive VP & Chief Commercial Officer Anthony Pagano - Executive VP & CFO ...

May 7, 2026 Copenhagen, Denmark; Interim Report for the Three Months Ended March 31, 2026 Highlights Genmab revenue increased 25% compared to the first three months of 2025 , to $896 million FDA approved an sBLA to remove the recommendation for 24-hour hospitalization fo...

Company Announcement Net sales of DARZALEX ® in the first quarter of 2026 totaled USD 3,964 million Genmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech, Inc.) COPENHAGEN, Denmark; April 14, 2026 – Ge...

2026-03-31 15:34:27 ET The last time I spoke about Bicara Therapeutics Inc. (BCAX), it was in a Seeking Alpha article entitled " Bicara: Stock Decline On FICERA Abstract Release Creates Buying Opportunity ." With respect to this article, I mentioned that the company had released...

2026-03-11 14:52:24 ET Genmab A/S (GMAB) Barclays 28th Annual Global Healthcare Conference March 11, 2026 1:30 PM EDT... Read the full article on Seeking Alpha For further details see: Genmab A/S (GMAB) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

2026-02-17 23:53:12 ET More on Genmab Genmab A/S (GMAB) Q4 2025 Earnings Call Transcript Genmab A/S 2025 Q4 - Results - Earnings Call Presentation Genmab: Darzalex Growth Fuels Rally, Upside Is Tight Genmab down after trial data for AbbVie-partnered Epkinly i...

2026-02-17 16:14:57 ET Genmab A/S (GMAB) Q4 2025 Earnings Call February 17, 2026 12:00 PM EST Company Participants Jan van de Winkel - Co-Founder, President & CEO Brad Bailey Anthony Pagano - Executive VP & CFO Tahamtan Ahmadi - Executive VP, Chief Me...

Company Announcement COPENHAGEN, Denmark; February 17, 2026 – Genmab A/S (Nasdaq: GMAB) announced today the publication of its Annual Report for 2025. Below is a summary of business progress in 2025, financial performance for the year and the financial outlook for 2026. The full...

2026-01-29 22:30:00 ET The following segment was excerpted from the Harbor Small Cap Growth Fund ( HASGX ) Q4 2025 Commentary. ... Read the full article on Seeking Alpha For further details see: Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance